Siegfried Holding

Siegfried Holding, headquartered in Switzerland (CH) and operating in Pharmaceutical Preparation Manufacturing, has disclosed its carbon emissions and ambitious climate commitments.

In 2025, Siegfried Holding reported total Scope 1 emissions of 52,000,000 kg CO2e, Scope 2 market-based emissions of 16,000,000 kg CO2e, and Scope 3 emissions of 621,000,000 kg CO2e. For 2024, Scope 1 emissions were 56,000,000 kg CO2e, Scope 2 market-based emissions were 15,000,000 kg CO2e, and Scope 3 emissions totalled 583,000,000 kg CO2e. In 2023, the company's Scope 1 emissions were 56,000,000 kg CO2e, Scope 2 market-based emissions were 19,000,000 kg CO2e, and Scope 3 emissions were 559,000,000 kg CO2e.

Siegfried Holding has set near-term Science Based Targets initiative (SBTi) approved targets to reduce absolute Scope 1 and 2 GHG emissions by 66.89% by 2033, against a 2020 base year. Additionally, the company commits to reducing absolute Scope 3 GHG emissions from fuel and energy related activities, upstream transportation and distribution, and waste generated in operations by 32.5% by 2033, against a 2022 base year. A key aspect of their Scope 3 reduction strategy is ensuring that 85% of their suppliers, by emissions covering purchased goods and services, have science-based targets by 2029.

For long-term goals, Siegfried Holding commits to reaching net-zero greenhouse gas emissions across its value chain by 2050. This includes a 90% reduction in absolute Scope 1 and 2 GHG emissions by 2050 from a 2020 base year. Furthermore, the company aims to reduce absolute Scope 3 GHG emissions from purchased goods and services, capital goods, upstream transportation and distribution, waste generated in operations, processing of sold products, and end-of-life treatment of sold products by 90% by 2050, from a 2022 base year. The company's targets are consistent with reductions required to keep global warming to 1.5°C.